Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) published its 2025 Impact Report on July 8, 2026, covering the company's activities from January ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE